RxeLite Inc. logo

RxeLite Inc. (RXEI)

Market Closed
11 Aug, 20:00
OTC GREY OTC GREY
$
0. 00
0
0%
$
1.48K Market Cap
- P/E Ratio
- Div Yield
200 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track RXEI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RXEI closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, RXEI stock gained 0%.
RXEI is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

RXEI Chart

People also search for

Rodedawg International Industries, Inc.
$ 0.02
0%
Man Sang International Ltd.
$ 0
0%
Molecule Holdings Inc.
$ 0
0%
Paion AG
$ 0.07
0%
Madison Sports & Entertainment Inc.
$ 0.01
0%

RxeLite Inc. (RXEI) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

RxeLite Inc. is listed on OTC GREY.

What is its stock symbol?

The ticker symbol is RXEI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.48K.

Has RxeLite Inc. ever had a stock split?

No, there has never been a stock split.

RxeLite Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Richard Tener CEO
OTC GREY Exchange
78347X105 CUSIP
US Country
47 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

RxElite, Inc. is a corporation that focuses on the development, manufacture, and marketing of generic prescription drug products targeting specialty generic markets. Situated in Meridian, Idaho, this company excels in bringing forth generic pharmaceuticals across various forms, including sterile liquid doses, injectables, and products for ophthalmic and respiratory use. Delving into the realm of pharmaceutical ingredient manufacturing, RxElite extends its expertise to support pharmaceutical companies across the United States, Europe, and Asia through its subsidiaries. With a customer base spanning hospitals, wholesalers, retail pharmacies, homecare companies, and outpatient centers, the company asserts its prominence in the healthcare sector. Operating under the aegis of Piramal Healthcare Ltd., RxElite nurtures strategic partnerships with organizations like Stason Pharmaceuticals, Inc., Alkem Laboratories Limited, and Zach Systems S.p.A., further solidifying its position in the market.

Products and Services

  • Sterile Liquid Dose Products:

    RxElite focuses on the production of sterile liquid dose pharmaceuticals, which include generic ophthalmic solutions available in both unit and multi-dose formats. This category also embraces sterile unit dose inhalation products for respiratory care, along with a variety of injectable drugs. These products cater to the needs of healthcare institutions requiring high-quality, sterile formulations for patient care.

  • Active Pharmaceutical Ingredients (API):

    The company exhibits prowess in manufacturing active pharmaceutical ingredients for a diverse clientele that includes pharmaceutical entities across the United States, Europe, and Asia. This service highlights RxElite’s capability in contributing to the broader pharmaceutical industry by supplying essential components used in drug formulation and production.

  • Customer Base:

    RxElite’s clientele is broad and varied, encompassing hospitals and hospital group purchasing organizations, national and regional wholesalers, retail pharmacy chains dedicated to stocking, homecare companies, and outpatient surgical centers as well as ambulatory care clinics. This wide-reaching customer base demonstrates the company's ability to meet the pharmaceutical needs of a diverse array of healthcare providers and settings.

Contact Information

Address: 1404 North Main
Phone: 208-288-5550